Ryland D Mortlock

7PUBLICATIONS
25CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)NanoelectronicsForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2025
Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.

Sepideh Hamzehlou, Ryland D Mortlock, Caroline Echeandia-Francis

|Aug 30, 2025
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.

Antonella Bacchiocchi, Michael Mak, Zerin Mahzabin Khan

|Aug 04, 2025
A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.

Xingyuan Jiang, Ryland D Mortlock, Nathalie Pironon

|May 30, 2025
Linear epidermal naevus associated with a novel mosaic heterozygous PTPN11 variant.

Xingyuan Jiang, Tiffany X Chen, Ronghua Hu

|Feb 06, 2025
Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.

Xingyuan Jiang, Ryland D Mortlock, Ivan B Lomakin

|May 18, 2024
Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys.

Alexandra S Piotrowski-Daspit, Laura G Bracaglia, David A Eaton

Pageof 2